Table 12: Mucosta SWOT Analysis, 2015 55 Table 13: Global Sales Forecast($ m) for Mucosta, 2014-2024 56 Table 14: Product Profile- Ikervis 60 Table 15: Ikervis SWOT Analysis, 2015 62 Table 16: Global Sales Forecast($ m) for Ikervis, 2014-2024 63 Table 17: Artificial Tears SWOT Analysis, 2015 70 Table 18: Global Sales Forecast($ m) for Artificial Tears, 2014-2024 71 Table 19: Unmet Needs and Opportunities in DES 77 Table 20: Promising Drugs in Clinical Development for Dry Eye Syndrome, 2015 102 Table 21: Comparison of Drugs in Development for Dry Eye Syndrome, 2015 103 Table 22: Product Profile- Lifitegrast 109
Browse Complete Summary Click Here @ http:// www. radiantinsights. com / research / dry-eyesyndrome-china-drug-forecast-and-market-analysis-to-2024
Table 23: SWOT Analysis- Lifitegrast, 2015 112 Table 24: Global Sales Forecast($ m) for Lifitegrast, 2014-2024 113 Table 25: Product Profile- Tavilermide 116 Table 26: SWOT Analysis- tavilermide, 2015 118 Table 27: Global Sales Forecast($ m) for tavilermide, 2014-2024 119 Table 28: Product Profile- Visomitin 122 Table 29: SWOT Analysis- Visomitin, 2015 124 Table 30: Global Sales Forecast($ m) for Visomitin, 2014-2024 125 Table 31: Product Profile- RGN-259 128 Table 32: SWOT Analysis- RGN-259, 2015 130
Table 33: Global Sales Forecast($ m) for RGN-259, 2014-2024 130 Table 34: Product Profile- Cis-UCA 132 Table 35: Product Profile- SI-614 134